Skip to content

Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery

Randomized Controlled Trial on the Effect of Intermittent Pedicle Clamping Using 15 or 30 Minutes Ischemic Intervals During Liver Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01099475
Enrollment
20
Registered
2010-04-07
Start date
2007-10-31
Completion date
2011-04-30
Last updated
2014-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss, Hepatocellular Injury

Keywords

liver surgery, pringle manoeuvre, hepatocellular damage, surgical complications, patients requiring liver surgery

Brief summary

In order to prevent excessive blood loss during liver surgery, an intermittent Pringle manoeuvre (IPM) can be applied. This implies a temporary clamping of the portal vein and hepatic artery in the hepatoduodenal ligament in order to occlude hepatic inflow. The optimal duration of the IPM is unknown. This randomized controlled trial aimed to analyse differences in hepatocellular damage after 15 minutes or 30 minutes IPM during liver surgery for primary or secondary liver tumours.

Detailed description

Surgical procedure Patients were anaesthetized using isoflurane and propofol. They routinely had an epidural catheter, urinary catheter, two peripheral venous catheters and indwelling catheters in a jugular vein and radial artery. Body temperature was maintained using a Bair Hugger system (Arizant Healthcare Inc. Eden Prairie, Minnesota). The surgical procedure was performed using a subcostal bilateral incision and Olivier retractors to improve exposure. After dissection of the teres hepatis ligament, the liver was mobilized. Thereafter, an intra-operative ultrasound was performed to define the position of the tumour in relation to vascular and biliary structures. As IPM was not routinely applied, a patient was randomized for 15 minted IPM (15IPM) or 30 minutes IPM (30IPM) only after the surgeon had decided a complete Pringle manoeuvre would be required. During 15IPM or 30IPM, the complete portal triad was clamped using a rubber sling. The time of inflow occlusion was adapted to the need according to the randomization protocol. Occasionally, the left or right pedicle was ligated after protocolled IPM. Five minutes reperfusion intervals were applied during which transection was stopped and cut surfaces were gently compressed to ensure hemostasis. A Cavitron Ultrasonic Surgical Aspirator (CUSA system 200 macrodissector, Cavitron Surgical Systems, Stamford, Connecticut) and Argon beam coagulation (Force GSU System, Valleylab, Boulder, Colorado) were used for liver transection. A stapler device or clamps were used for transection of the hepatic veins. Central venous pressure was maintained below 5 centimetre of water (cm H2O) during transection to reduce venous back-bleeding. After surgery, the weight of the resection specimen was recorded. Perioperative care was protocolled, as described earlier.

Interventions

PROCEDUREPringle manoeuvre 15 minutes

During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion

PROCEDUREPringle manoeuvre 30 minutes

During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients \> 18 years of age and \< 100 years of age * primary or secondary liver tumours requiring liver surgery

Exclusion criteria

* pre-existent liver disease (e.g. inflammatory liver disease, cirrhosis, inborn errors of metabolism) * cholangiocarcinoma requiring biliary tract reconstruction during surgery * steroid hormone medication * tumours deemed irresectable during liver surgery * laparoscopic liver surgery

Design outcomes

Primary

MeasureTime frameDescription
Hepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) LevelsL-FABP area under curve from start of surgery up until postoperative day 3At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by L-FABP) level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3. This continuous variable with repeated measurements was summarized as area under the curve (AUC) from baseline to postoperative day 3 (as described in Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Bmj 1990;300:230-5).

Secondary

MeasureTime frameDescription
Post-resectional Complicationswithin 90-days after initial liver surgerymorbidity and mortality occuring after liver surgery graded according to Clavien-Dindo's grading system. In short, any deviation from the postoperative course without the need for pharmacological, radiological or surgical intervention was classified as Clavien-Dindo grade 1; complications requiring pharmacological treatment were graded as grade 2; complications requiring surgical or radiological intervention not under general anesthesia as grade 3a and under general anesthesia as grade 3b; grade 4 complications were life-threatening complications requiring intensive care unit care because of single organ dysfunction (grade 4a) or multiple organ dysfunction (grade 4b); mortality was classed as grade 5.
Amount of Blood Lossat the end of liver surgery, an average of 225 minutesamount of blood in the suction container (and, if applicable, in the weighted gauzes)
Hepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) LevelsALAT area under curve from start of surgery up until postoperative day 3At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by ALAT level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3.

Countries

Netherlands

Participant flow

Recruitment details

Inclusion of participants: Oct 2007 - Jul 2009 Location: Department of Surgery, Maastricht University Medical Centre

Participants by arm

ArmCount
Pringle Manoeuvre Using 15 Minutes Inflow Occlusion
When intermittent pedicle occlusion during parenchymal transection is necessary, 2 cycles of 15 minutes of hepatic inflow occlusion will be applied each followed by 5 minutes of reperfusion. Pringle manoeuvre using 15 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 2-times 15 minutes with 5 minutes reperfusion
10
Pringle Manoeuvre Using 30 Minutes Inflow Occlusion
When intermittent pedicle occlusion during parenchymal transection is necessary, 1 cycle of 30 minutes of hepatic inflow occlusion will be applied followed by 5 minutes of reperfusion Pringle Manoeuvre using 30 minutes ischemic interval: During parenchymal transection, the hepatoduodenal ligament will be clamped by a rubber band for 30 minutes with 5 minutes reperfusion
10
Total20

Baseline characteristics

CharacteristicPringle Manoeuvre Using 15 Minutes Inflow OcclusionPringle Manoeuvre Using 30 Minutes Inflow OcclusionTotal
Age, Continuous64 years62 years62 years
American Society of Anesthesiologists (ASA) classification
ASA 1
0 participants2 participants2 participants
American Society of Anesthesiologists (ASA) classification
ASA 2
8 participants5 participants13 participants
American Society of Anesthesiologists (ASA) classification
ASA 3
2 participants3 participants5 participants
Indication for resection
benign disease
0 participants1 participants1 participants
Indication for resection
malignant disease
10 participants9 participants19 participants
Region of Enrollment
Netherlands
10 participants10 participants20 participants
Sex: Female, Male
Female
4 Participants4 Participants8 Participants
Sex: Female, Male
Male
6 Participants6 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Hepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) Levels

At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by L-FABP) level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3. This continuous variable with repeated measurements was summarized as area under the curve (AUC) from baseline to postoperative day 3 (as described in Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Bmj 1990;300:230-5).

Time frame: L-FABP area under curve from start of surgery up until postoperative day 3

ArmMeasureValue (MEAN)Dispersion
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionHepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) Levels9097 ng*h/mLStandard Error 1781
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionHepatocellular Damage Reflected by Liver Fatty-acid Binding Protein (L-FABP) Levels11,688 ng*h/mLStandard Error 2247
Secondary

Amount of Blood Loss

amount of blood in the suction container (and, if applicable, in the weighted gauzes)

Time frame: at the end of liver surgery, an average of 225 minutes

ArmMeasureValue (MEDIAN)
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionAmount of Blood Loss575 mL
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionAmount of Blood Loss450 mL
Secondary

Hepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) Levels

At specific time points before, during and after liver surgery, plasma samples will be obtained to analyse the amount of hepatocellular damage reflected by ALAT level. These timepoints include: baseline (before operation), just before intermittent pedicle clamping, just before end of 15 or 30 minutes pedicle clamping, end of 5 minutes reperfusion, end of liver surgery, 8 hours after start liver surgery, postoperative day 1, 2 and 3.

Time frame: ALAT area under curve from start of surgery up until postoperative day 3

ArmMeasureValue (MEAN)Dispersion
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionHepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) Levels3196 IU*h/LStandard Error 797
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionHepatocellular Damage Reflected by Alanine Aminotransferase (ALAT) Levels3609 IU*h/LStandard Error 812
Secondary

Post-resectional Complications

morbidity and mortality occuring after liver surgery graded according to Clavien-Dindo's grading system. In short, any deviation from the postoperative course without the need for pharmacological, radiological or surgical intervention was classified as Clavien-Dindo grade 1; complications requiring pharmacological treatment were graded as grade 2; complications requiring surgical or radiological intervention not under general anesthesia as grade 3a and under general anesthesia as grade 3b; grade 4 complications were life-threatening complications requiring intensive care unit care because of single organ dysfunction (grade 4a) or multiple organ dysfunction (grade 4b); mortality was classed as grade 5.

Time frame: within 90-days after initial liver surgery

ArmMeasureGroupValue (NUMBER)
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complicationsbile leakage4 participants
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complicationssepsis1 participants
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complicationsintra-abdominal hemorrhage0 participants
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complicationspost-resectional liver failure2 participants
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complicationsascites1 participants
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complications30-day mortality1 participants
Pringle Manoeuvre Using 15 Minutes Inflow OcclusionPost-resectional Complicationsintra-abdominal abscess3 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complications30-day mortality1 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complicationsintra-abdominal abscess2 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complicationsintra-abdominal hemorrhage1 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complicationsbile leakage1 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complicationsascites0 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complicationssepsis2 participants
Pringle Manoeuvre Using 30 Minutes Inflow OcclusionPost-resectional Complicationspost-resectional liver failure1 participants

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026